Target ACE2, Spike protein
(Unterschied zwischen Versionen)
K |
K |
||
Zeile 5: | Zeile 5: | ||
{{ttp|p=32449939|t=2020. SARS-CoV-2 spike glycoprotein-binding proteins expressed by upper respiratory tract bacteria may prevent severe viral infection.|pdf=|usr=007}} | {{ttp|p=32449939|t=2020. SARS-CoV-2 spike glycoprotein-binding proteins expressed by upper respiratory tract bacteria may prevent severe viral infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32582574|t=2020. ACE2, Much More Than Just a Receptor for SARS-COV-2.|pdf=|usr=011}} | ||
+ | {{tp|p=32738617|t=2020. ACE2 Co-evolutionary Pattern Suggests Targets for Pharmaceutical Intervention in the COVID-19 Pandemic.|pdf=|usr=018}} | ||
Zeile 15: | Zeile 17: | ||
{{qt|PHA ACE2 soluble ace2}} | {{qt|PHA ACE2 soluble ace2}} | ||
{{qt|RSP - On RAS drugs}} | {{qt|RSP - On RAS drugs}} | ||
− | + | {{qt|MOD ACE2 transgenic mice}} | |
{{qt|PHA ACE2 ace2 species specificity clade specificity}} | {{qt|PHA ACE2 ace2 species specificity clade specificity}} |
Version vom 27. April 2021, 17:50 Uhr
ACE2; any specific functions of spike protein;
PHA antivirals by mechanism |
PHA pharmacophore by screened target |
32449939 2020. SARS-CoV-2 spike glycoprotein-binding proteins expressed by upper respiratory tract bacteria may prevent severe viral infection. |
32582574 2020. ACE2, Much More Than Just a Receptor for SARS-COV-2.
32738617 2020. ACE2 Co-evolutionary Pattern Suggests Targets for Pharmaceutical Intervention in the COVID-19 Pandemic.
PHA ACE2 Structure spike-ace2 |
PHA ACE2 in target tissues |
PHA ACE2 regulation of ACE2 |
PHA ACE2 drug design |
PHA ACE2 amplification |
PHA ACE2 soluble ace2 |
RSP - On RAS drugs |
MOD ACE2 transgenic mice |
PHA ACE2 ace2 species specificity clade specificity |